X0306 4 2022-04-01 false 0001531048 Inari Medical, Inc. NARI 0001806431 Hykes Andrew C/O INARI MEDICAL, INC. 6001 OAK CANYON, SUITE 100 IRVINE CA 92618 false true false false Chief Operating Officer Common Stock 2022-04-01 4 F false 347.00 90.92 D 167630.00 D Common Stock 2022-04-01 4 F false 646.00 90.92 D 166984.00 D Common Stock 2022-04-01 4 S false 2607.00 89.76 D 164377.00 D Common Stock 2022-04-01 4 S false 1020.00 90.73 D 163357.00 D Common Stock 2022-04-01 4 S false 1373.00 91.86 D 161984.00 D Common Stock 2022-04-01 4 S false 3394.00 91.63 D 158590.00 D Common Stock 2022-04-01 4 S false 1606.00 92.10 D 156984.00 D Common Stock 1550.00 I By Child 1 Common Stock 1550.00 I By Child 2 Common Stock 1550.00 I By Child 3 Common Stock 1000.00 I By Spouse Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021. Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021. This transaction was executed in multiple trades at prices ranging from $89.23 to $90.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $90.30 to $91.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $91.31 to $92.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $90.99 to $91.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $92.00 to $92.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Angela Ahmad, attorney-in-fact for 2022-04-05